Breakthrough trial aims to free kidney patients from lifelong pills
Disease control
Recruiting now
This study tests a new approach to help kidney transplant recipients accept their new organ without needing lifelong anti-rejection medication. Participants receive a special combination of radiation and a drug, followed by a stem cell infusion from the same sibling who donated t…
Phase: PHASE1, PHASE2 • Sponsor: Jeffrey Veale, MD • Aim: Disease control
Last updated May 04, 2026 16:23 UTC